Nebraska Cancer Specialists - Omaha — Omaha, Nebraska

Nebraska Cancer Specialists - Omaha is a clinical research site located in Omaha, Nebraska, United States 68124.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialists - Omaha has participated in 47 clinical trials with 29 currently active.

Therapeutic areas: Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma.

Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), SWOG Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialists - Omaha?

Nebraska Cancer Specialists - Omaha has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialists - Omaha conducted?

Nebraska Cancer Specialists - Omaha has 47 clinical trials on record, with 29 currently active. Their work covers Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma.

Is Nebraska Cancer Specialists - Omaha accredited by Crixeo Clinical Trials?

Nebraska Cancer Specialists - Omaha has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialists - Omaha?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.